BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24169717)

  • 1. N-substituted Indole-2 and 3-carboxamide derivatives as inhibitors of human protein kinase CK2: in vitro assay and molecular modelling study.
    Olgen S; Gratz A; Kurt ZK; Jose J
    Acta Chim Slov; 2013; 60(3):628-35. PubMed ID: 24169717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indeno[1,2-b]indole derivatives as a novel class of potent human protein kinase CK2 inhibitors.
    Hundsdörfer C; Hemmerling HJ; Götz C; Totzke F; Bednarski P; Le Borgne M; Jose J
    Bioorg Med Chem; 2012 Apr; 20(7):2282-9. PubMed ID: 22377675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of novel substituted pyrrolo[1,2-a]quinoxaline derivatives as inhibitors of the human protein kinase CK2.
    Guillon J; Le Borgne M; Rimbault C; Moreau S; Savrimoutou S; Pinaud N; Baratin S; Marchivie M; Roche S; Bollacke A; Pecci A; Alvarez L; Desplat V; Jose J
    Eur J Med Chem; 2013 Jul; 65():205-22. PubMed ID: 23711832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QSAR Model of Indeno[1,2-
    Haidar S; Marminon C; Aichele D; Nacereddine A; Zeinyeh W; Bouzina A; Berredjem M; Ettouati L; Bouaziz Z; Le Borgne M; Jose J
    Molecules; 2019 Dec; 25(1):. PubMed ID: 31888043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diversity-oriented synthesis of pyrazolo[4,3-b]indoles by gold-catalysed three-component annulation: application to the development of a new class of CK2 inhibitors.
    Hou Z; Oishi S; Suzuki Y; Kure T; Nakanishi I; Hirasawa A; Tsujimoto G; Ohno H; Fujii N
    Org Biomol Chem; 2013 May; 11(20):3288-96. PubMed ID: 23535832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of substituted (thieno[2,3-d]pyrimidin-4-ylthio)carboxylic acids as inhibitors of human protein kinase CK2.
    Golub AG; Bdzhola VG; Briukhovetska NV; Balanda AO; Kukharenko OP; Kotey IM; Ostrynska OV; Yarmoluk SM
    Eur J Med Chem; 2011 Mar; 46(3):870-6. PubMed ID: 21276643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and pp60c-Src tyrosine kinase inhibitory activities of novel indole-3-imine and amine derivatives substituted at N1 and C5.
    Kiliç Z; Isgör YG; Olgen S
    Arch Pharm (Weinheim); 2009 Jun; 342(6):333-43. PubMed ID: 19475593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of 3-(substituted-benzylidene)-1,3-dihydro-indolin derivatives as human protein kinase CK2 and p60(c-Src) tyrosine kinase inhibitors.
    Olgen S; Götz C; Jose J
    Biol Pharm Bull; 2007 Apr; 30(4):715-8. PubMed ID: 17409508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel indeno[1,2-b]indoloquinones as inhibitors of the human protein kinase CK2 with antiproliferative activity towards a broad panel of cancer cell lines.
    Hundsdörfer C; Hemmerling HJ; Hamberger J; Le Borgne M; Bednarski P; Götz C; Totzke F; Jose J
    Biochem Biophys Res Commun; 2012 Jul; 424(1):71-5. PubMed ID: 22728884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of new analogs of benzotriazole, benzimidazole and phthalimide--potential inhibitors of human protein kinase CK2.
    Najda-Bernatowicz A; Łebska M; Orzeszko A; Kopańska K; Krzywińska E; Muszyńska G; Bretner M
    Bioorg Med Chem; 2009 Feb; 17(4):1573-8. PubMed ID: 19168362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of polyoxometalates as nanomolar noncompetitive inhibitors of protein kinase CK2.
    Prudent R; Moucadel V; Laudet B; Barette C; Lafanechère L; Hasenknopf B; Li J; Bareyt S; Lacôte E; Thorimbert S; Malacria M; Gouzerh P; Cochet C
    Chem Biol; 2008 Jul; 15(7):683-92. PubMed ID: 18635005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Converting potent indeno[1,2-b]indole inhibitors of protein kinase CK2 into selective inhibitors of the breast cancer resistance protein ABCG2.
    Jabor Gozzi G; Bouaziz Z; Winter E; Daflon-Yunes N; Aichele D; Nacereddine A; Marminon C; Valdameri G; Zeinyeh W; Bollacke A; Guillon J; Lacoudre A; Pinaud N; Cadena SM; Jose J; Le Borgne M; Di Pietro A
    J Med Chem; 2015 Jan; 58(1):265-77. PubMed ID: 25272055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based design, synthesis, and study of pyrazolo[1,5-a][1,3,5]triazine derivatives as potent inhibitors of protein kinase CK2.
    Nie Z; Perretta C; Erickson P; Margosiak S; Almassy R; Lu J; Averill A; Yager KM; Chu S
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4191-5. PubMed ID: 17540560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity.
    Łukowska-Chojnacka E; Wińska P; Wielechowska M; Poprzeczko M; Bretner M
    Bioorg Med Chem; 2016 Feb; 24(4):735-41. PubMed ID: 26778657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and proapoptotic properties of new casein kinase II inhibitors.
    Koronkiewicz M; Zukowska M; Chilmonczyk Z; Orzeszko A; Kazimierczuk Z
    Acta Pol Pharm; 2010; 67(6):635-41. PubMed ID: 21229880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inspecting the structure-activity relationship of protein kinase CK2 inhibitors derived from tetrabromo-benzimidazole.
    Battistutta R; Mazzorana M; Sarno S; Kazimierczuk Z; Zanotti G; Pinna LA
    Chem Biol; 2005 Nov; 12(11):1211-9. PubMed ID: 16298300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrochemical screening of the indole/quinolone derivatives as potential protein kinase CK2 inhibitors.
    Martić S; Tackenburg S; Bilokin Y; Golub A; Bdzhola V; Yarmoluk S; Kraatz HB
    Anal Biochem; 2012 Feb; 421(2):617-21. PubMed ID: 22178909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A subnanomolar fluorescent probe for protein kinase CK2 interaction studies.
    Enkvist E; Viht K; Bischoff N; Vahter J; Saaver S; Raidaru G; Issinger OG; Niefind K; Uri A
    Org Biomol Chem; 2012 Nov; 10(43):8645-53. PubMed ID: 23032938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of CK2 inhibitors with new scaffolds by a hybrid virtual screening approach based on Bayesian model; pharmacophore hypothesis and molecular docking.
    Di-wu L; Li LL; Wang WJ; Xie HZ; Yang J; Zhang CH; Huang Q; Zhong L; Feng S; Yang SY
    J Mol Graph Model; 2012 Jun; 36():42-7. PubMed ID: 22516037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, docking and in vitro anticancer evaluation of some new benzopyrone derivatives.
    El-Ansary SL; Hussein MM; Abdel Rahman DE; Abdel Ghany LM
    Bioorg Chem; 2014 Apr; 53():50-66. PubMed ID: 24607350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.